Industry Newsai enabled caredigital mskhinge healthwearables
Hinge Health Garners Bullish Analyst Targets
7.0
Analysts are bullish on Hinge Health (HNGE), with all 12 covering analysts assigning Buy ratings and a consensus one-year target of $67.53 as of December 19, implying a 42.9% upside. On December 12 Citizens reiterated a Buy with a $65 target, citing the company’s contracts with the top five national health plans and three major PBMs. Hinge Health uses an AI-enabled musculoskeletal care model and an FDA-approved wearable for drug-free pain management.
Key Points
- 1Show consensus: 12 analysts assign Buy, one-year target $67.53 implying 42.9% upside
- 2Highlight strong market position via contracts with top 5 health plans and three major PBMs
- 3Indicate potential growth: AI-enabled MSK care, FDA-approved wearable, scalable drug-free pain solutions
Scoring Rationale
Analyst consensus and credible partnerships drive relevance, but limited novelty and company-specific scope constrain broader impact.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
